ONMBF yields 3.55% · PFE yields 6.13%● Live data
📍 ONMBF pulled ahead of the other in Year 1
Combined, ONMBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ONMBF + PFE for your $10,000?
Onamba Co., Ltd. manufactures and sells electronic components, general-purpose electric wires, and communication cables for consumer electronic devices, information office equipment, and industrial electronic devices in Japan. The company offers wires and cable for machine internal; coaxial cables; cables for medical and antibacterial, solar power generation, and fixed and moving applications; environmentally friendly cable; and harnesses for automobile, industrial equipment, and consumer products. It also provides renewable energy resources products, including PVU-Finder, a solar power generation intelligent monitoring and control system; and E&E-Solution, a self-consumption integrated system. In addition, the company offers junction boxes, cables for solar power generation systems, as well as branch boxes/extension and crossing cables; and connectors for automobile and harness processing equipment and machinery. Its products are used for power, control and communications, and solar power generation applications. Onamba Co., Ltd. was incorporated in 1941 and is headquartered in Osaka, Japan.
Full ONMBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.